Toxicity and efficacy of antibody drug conjugates (ADC) in advanced solid tumors: A pooled analysis of Sarah Cannon UK

被引：0
|
作者：
Woodford, R. [1 ]
Beygozlu, N. [2 ]
Cammarota, A. [3 ]
Joshi, K. [4 ]
Grochot, R. M. [5 ]
Williams, A. [6 ]
Fontana, E. [5 ]
机构：
[1] Sarah Cannon Res Inst SCRI UK, Med Oncol Dept, London, England
[2] UCL, Sci & Technol, London, England
[3] Humanitas Univ, Med Oncol Dept, Milan, Italy
[4] Sarah Cannon Res Inst SCRI UK, London, England
[5] Sarah Cannon Res Inst SCRI UK, Drug Dev Unit, London, England
[6] Sarah Cannon Res Inst SCRI UK, Med Oncol, London, England
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.721
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
655P
引用
收藏
页码：S517 / S518
页数：2
相关论文
共 50 条
  • [1] Investigational antibody drug conjugates for solid tumors
    Sapra, Puja
    Hooper, Andrea T.
    O'Donnell, Christopher J.
    Gerber, Hans-Peter
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (08) : 1131 - 1149
  • [2] Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis
    Pedersini, Rebecca
    Buffoni, Martina
    Petrelli, Fausto
    Ghidini, Antonio
    di Mauro, Pierluigi
    Amoroso, Vito
    Parati, Maria Chiara
    Laini, Lara
    Cosentini, Deborah
    Schivardi, Greta
    Ippolito, Giuseppe
    Berruti, Alfredo
    Lagana, Marta
    CLINICAL BREAST CANCER, 2024, 24 (05) : 411 - 420
  • [3] Biomarkers for Antibody-Drug Conjugates in Solid Tumors
    Katrini, Jalissa
    Boldrini, Laura
    Santoro, Celeste
    Valenza, Carmine
    Trapani, Dario
    Curigliano, Giuseppe
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (04) : 436 - 446
  • [4] Gastrointestinal toxicity of antibody-drug conjugates (ADCs) in metastatic breast cancer: A pooled analysis
    di Mauro, Pierluigi
    Pedersini, Rebecca
    Petrelli, Fausto
    Ghidini, Antonio
    Amoroso, Vito
    Laini, Lara
    Parati, Maria Chiara
    Bossi, Paolo
    Berruti, Alfredo
    CANCER RESEARCH, 2022, 82 (04)
  • [5] Antibody-drug conjugates in solid tumors: a new frontier
    Jaime-Casas, Salvador
    Barragan-Carrillo, Regina
    Tripathi, Abhishek
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (05) : 421 - 429
  • [6] Antibody–drug conjugates in solid tumors: a look into novel targets
    Carmen Criscitiello
    Stefania Morganti
    Giuseppe Curigliano
    Journal of Hematology & Oncology, 14
  • [7] Antibody–Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review
    John M. Lambert
    Charles Q. Morris
    Advances in Therapy, 2017, 34 : 1015 - 1035
  • [8] Antibody-drug conjugates in solid tumors: a look into novel targets
    Criscitiello, Carmen
    Morganti, Stefania
    Curigliano, Giuseppe
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [9] Global research progress in antibody-drug conjugates for solid tumors: Bibliometrics and visualized analysis
    Fang, Wenjun
    Ma, Xueqing
    Liu, Ben
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)
  • [10] Efficacy of antibody drug conjugate (ADC) by mRNA expression of targeted genes in advanced solid tumors: SCRUM-Japan MONSTAR-SCREEN-2
    Fujisawa, T.
    Nakamura, Y.
    Sakamoto, N.
    Hashimoto, T.
    Nagamine, M.
    Kuwata, T.
    Ishii, G.
    Yamashita, R.
    Morizane, C.
    Nonomura, N.
    Iwata, H.
    Okano, S.
    Watari, H.
    Namikawa, K.
    Shibuki, T.
    Imai-Sumida, M.
    Bando, H.
    Radovich, M.
    Sledge, G.
    Yoshino, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S297 - S298
12345